Nautilus Biotechnology Inc

NASDAQ NAUT

Data sourced from

and

Download Data

Nautilus Biotechnology Inc Dividend Payout Ratio for the Trailing 12 Months (TTM) ending March 31, 2024

Nautilus Biotechnology Inc Dividend Payout Ratio is NA for the Trailing 12 Months (TTM) ending March 31, 2024. The dividend payout ratio measures the percentage of a company's net income that is distributed as dividends to shareholders. It is calculated by dividing dividends paid by net income. This ratio provides insights into the portion of earnings that is returned to shareholders in the form of dividends. A higher ratio indicates a larger proportion of earnings being paid out as dividends.

Nautilus Biotechnology Inc Dividend Payout Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was -0.51%.

NASDAQ: NAUT

Nautilus Biotechnology Inc

CEO	Mr. Sujal M. Patel
IPO Date	June 10, 2021
Location	United States
Headquarters	2701 Eastlake Avenue East, Seattle, WA, United States, 98102
Employees	163
Sector	Healthcare
Industry	Biotechnology

Description

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Key trends